Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1499, 2005-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Gemcitabine plus docetaxel `has moderate activity' in advanced pancreatic cancer
Inpharma, Vol. 1, Iss. 1281, 2001-01 ,pp. :
A phase II study of isoflavones, erlotinib, and gemcitabine in advanced pancreatic cancer
By El-Rayes Bassel Philip Philip Sarkar Fazlul Shields Anthony Ferris Ann Hess Kenneth Kaseb Ahmad Javle Milind Varadhachary Gauri Wolff Robert Abbruzzese James
Investigational New Drugs, Vol. 29, Iss. 4, 2011-08 ,pp. :